C07C 235/88
Carboxylic acid amides, the carbon skeleton of the acid part being further
Official title: having the nitrogen atom of at least one of the carboxamide groups further acylated
C07C235/88 (Carboxylic acid amides, the carbon skeleton of the acid part being further) appears on 46 US grants and 47 published applications in this corpus.
Search patents in C07C- Granted patents
- 46
- Published applications
- 47
- Assignees
- 38
- Inventors
- 151
- Latest grant
- 7 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 2 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 0 |
| 2004 | 0 | 1 |
| 2005 | 1 | 2 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 1 |
| 2011 | 1 | 1 |
| 2012 | 0 | 2 |
| 2013 | 1 | 2 |
| 2014 | 2 | 3 |
| 2015 | 1 | 4 |
| 2016 | 6 | 4 |
| 2017 | 3 | 2 |
| 2018 | 3 | 4 |
| 2019 | 3 | 2 |
| 2020 | 1 | 2 |
| 2021 | 2 | 0 |
| 2022 | 0 | 3 |
| 2023 | 2 | 4 |
| 2024 | 3 | 3 |
| 2025 | 2 | 6 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for treatment of platinum-based chemotherapeutic resistant tumors7 Apr 2026US 12,595,227 B2The George Washington University
- Cannabinoid derivatives10 Jun 2025US 12,325,709 B2Canopy Growth Corporation
- MASP-2 inhibitors and methods of use14 Jan 2025US 12,195,427 B2Omeros Corporation
- Prodrugs of fumarates and their use in treating various diseases3 Sep 2024US 12,076,306 B2Alkermes Pharma Ireland Limited
- Hydrogen-bonded organic framework nanosheet, preparation method and application thereof12 Mar 2024US 11,926,774 B1Yantai University
- Masp-2 inhibitors and methods of use9 Jul 2026US 2026/0193179 A9Omeros Corporation
- Masp-2 inhibitors and methods of use11 Dec 2025US 2025/0376443 A1Omeros Corporation
- Masp-2 inhibitors and methods of use4 Dec 2025US 2025/0368604 A1Omeros Corporation
- Antimicrobial agents26 Jun 2025US 2025/0206755 A1Rutgers, The State University of New Jersey
- Prodrugs of Fumarates and Their Use in Treating Various Diseases24 Apr 2025US 2025/0127747 A1Alkermes Pharma Ireland Limited
Most cited
By later US patents
- Tyrosine kinase inhibitors and benzoylacrylamide derivatives27US 5,618,829 AMitsubishi Chemical Corporation · 1997
- N-acyl-N-naphthoylglycines as aldose reductase inhibitors14US 4,925,968 AAmerican Home Products Corporation · 1990
- Prodrugs of fumarates and their use in treating various diseases9US 9,505,776 B2Alkermes Pharma Ireland Limited · 2016
- Prodrugs of fumarates and their use in treating various diseases8US 9,775,823 B2Alkermes Pharma Ireland Limited · 2017
- Pharmaceutical compounds7US 5,480,873 ALilly Industries Limited · 1996